Dr. Agarwal’s Eye Hospital Ltd, a 68-year-old healthcare company, is now managed by Prof. Amar Agarwal (Chairman), Dr. Athiya Agarwal (Director), Dr. Adil Agarwal (CEO), and a workforce of more than 1,133 people. The company offers various eye treatment facilities, including Cataract, Fungal Keratitis, Diabetic Retinopathy, Macular Edema, and Blepharitis, among others. They have a global presence in 10 countries with 250-plus eye hospitals. They have grown by over 2000% in their share price in the last 5 years. However, their revenue is 402 crore, and net income is 54 crore for FY 2024-25.

Establishment

Chennai in 1957 by Dr. Jaiveer Agarwal and Dr. Tahira Agarwal

Website

https://www.dragarwal.com

Company Listed On

National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)

Core Business

A network of eye hospitals and clinics

Financial Performance

It has a positive revenue growth and profit margin

Future Outlook

1. Acquisition of new hospitals/clinics
2. Growing demand for eye care services
3. Drive in ageing population and increased number of lifestyle-related vision issues
4. Integration of advanced technologies in the services
5. Strong investment backup

Disclaimer:

Unsold 70 publishes research-based articles, blogs, news, and company profiles to help readers understand businesses along with their future prospects. It will help you learn about the stock market and mutual funds. We research the companies as per our algorithm and find companies that need further research. However, the Dr Agarwal’s Eye Hospital profile is not an investment recommendation, as past performance does not guarantee future results. You should perform your own research and seek advice from a SEBI-registered financial advisor before making investment decisions. Visit our weekly research page to know about the research work done by our research team. It will help you to take up the companies for further research.